Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct 28;3(2):90-3.
doi: 10.1016/j.lrr.2014.09.001. eCollection 2014.

Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma

Affiliations

Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma

Gioacchino Catania et al. Leuk Res Rep. .

Abstract

Hepatosplenic T cell lymphoma (HSTCL) is a type of hematologic neoplasia with a poor prognosis and a high frequency of refractoriness to conventional chemotherapy. The results obtained by high dose chemotherapy followed by autologous stem cells transplantation seem to be a more effective option but still unsatisfactory. Also the role of allogeneic stem cell transplantation is still unclear, although the few cases reported on the literature would seem to show good results in overall survival rates. In this paper, we reported the patient׳s medical history affected by a αβ variant of hepatosplenic T cell successfully rescued with a haploidentical transplant.

Keywords: Haploidentical-SCT; Hepatosplenic T-cell lymphoma; TCR rearrangement; αβ T-lymphocytes.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Liver biopsy demonstrating a monomorphic, mostly intrasinusoidal, lymphoid infiltrate (arrow) composed of small to medium size cells (H&E stain, 500×).
Fig. 2
Fig. 2
PCR analysis of TCRβ gene rearrangement using BIOMED-2 protocol. Genescan clonality profiles of bone marrow aspirates at diagnosis (A) and after allogeneic stem cells transplantation (B). Clonal products (arrows) at diagnosis are no more visible at follow up after allogeneic transplantion and a different oligoclonal pattern emerge.

References

    1. Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia. 2000;14:991–997. - PubMed
    1. Belhadj K., Reyes F., Farcet J.P. Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003;102:4261–4269. - PubMed
    1. Chalmers A.W., Katz D.A., Miller I.J., Gregory S.A. Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant. Clin Adv Hematol Oncol. 2013;11:109–113. - PubMed
    1. Voss M.H., Lunning M.A., Maragulia J.C. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience. Clin Lymphoma Myeloma Leuk. 2013;13:8–14. - PMC - PubMed
    1. Dodero A., Spina F., Narni F. Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect. Leukemia. 2012;26:520–526. - PubMed

LinkOut - more resources